Skip to main navigation

Top Menu

JOIN US
CONTACT US

Main Corporate Nav

About Us
The Need
Our Approach
Pipeline
Patients & Families
- Genetic Testing
- Patients and Families
Investors
Join Us
Contact Us

Press Releases

Year

May 17, 2022

Decibel Therapeutics to Present at the H.C. Wainwright Global Investment Conference

May 12, 2022

Decibel Therapeutics Reports First Quarter 2022 Financial Results and Corporate Update

May 2, 2022

Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting

March 22, 2022

Decibel Therapeutics to Participate in Upcoming Investor Conferences

March 18, 2022

Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

February 10, 2022

Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

February 9, 2022

Decibel Therapeutics Reports on Continued Progress of Lead Gene Therapy Product Candidate DB-OTO and Presents Promising Preclinical Data Supporting Importance of Cell-Selective Transgene Expression Across Gene Therapy Pipeline

January 31, 2022

Decibel Therapeutics to Present at the 45th Annual Association for Research in Otolaryngology (ARO) Meeting

January 4, 2022

Decibel Therapeutics to Present at the H.C. Wainwright BioConnect Conference

Shareholder Tools

Contact IR
Contact IR

Email Alerts
Email Alerts

Print Page
Print Page

RSS Feeds
RSS Feeds

Search
Search

© Decibel Therapeutics, Inc. 2022. All rights reserved.

Privacy Notice
Terms of Use

Twitter
LinkedIn

Main Corporate Nav

About Us
The Need
Our Approach
Pipeline
Patients & Families
- Genetic Testing
- Patients and Families
Investors
Join Us
Contact Us